- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The effects of corticosteroids on COPD lung macrophages: a pooled analysis ; volume:16 ; number:1 ; day:20 ; month:8 ; year:2015 ; pages:1-9 ; date:12.2015
Respiratory research ; 16, Heft 1 (20.8.2015), 1-9, 12.2015
- Urheber
-
Higham, Andrew
- Beteiligte Personen und Organisationen
-
Booth, George
Lea, Simon
Southworth, Thomas
Plumb, Jonathan
Singh, Dave
SpringerLink (Online service)
- DOI
-
10.1186/s12931-015-0260-0
- URN
-
urn:nbn:de:1111-2016110724554
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Higham, Andrew
- Booth, George
- Lea, Simon
- Southworth, Thomas
- Plumb, Jonathan
- Singh, Dave
- SpringerLink (Online service)
Ähnliche Objekte (12)
Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients with COPD: Pooled Results of Randomized Placebo-Controlled Trials
The use of corticosteroids in patients with COPD or asthma does not decrease lung squamous cell carcinoma
Inhaled corticosteroids, COPD, and the incidence of lung cancer: a systematic review and dose response meta-analysis
Assessment of high-dose inhalational corticosteroids vs systemic corticosteroids in acute exacerbations of COPD in diabetic patients
Regulation of YKL-40 expression by corticosteroids: effect on pro-inflammatory macrophages in vitro and its modulation in COPD in vivo
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
Role of PRMT7 in the recruitment of monocyte-derived macrophages into lung tissue and COPD pathogenesis
Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation
Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial
Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study
Inhaled corticosteroids in COPD and the risk for coronary heart disease: a nationwide cohort study
Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis
Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients with COPD: Pooled Results of Randomized Placebo-Controlled Trials
The use of corticosteroids in patients with COPD or asthma does not decrease lung squamous cell carcinoma
Inhaled corticosteroids, COPD, and the incidence of lung cancer: a systematic review and dose response meta-analysis
Assessment of high-dose inhalational corticosteroids vs systemic corticosteroids in acute exacerbations of COPD in diabetic patients
Regulation of YKL-40 expression by corticosteroids: effect on pro-inflammatory macrophages in vitro and its modulation in COPD in vivo
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
Role of PRMT7 in the recruitment of monocyte-derived macrophages into lung tissue and COPD pathogenesis
Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation
Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial
Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study
Inhaled corticosteroids in COPD and the risk for coronary heart disease: a nationwide cohort study
Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis
Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients with COPD: Pooled Results of Randomized Placebo-Controlled Trials
The use of corticosteroids in patients with COPD or asthma does not decrease lung squamous cell carcinoma
Inhaled corticosteroids, COPD, and the incidence of lung cancer: a systematic review and dose response meta-analysis
Assessment of high-dose inhalational corticosteroids vs systemic corticosteroids in acute exacerbations of COPD in diabetic patients
Regulation of YKL-40 expression by corticosteroids: effect on pro-inflammatory macrophages in vitro and its modulation in COPD in vivo
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
Role of PRMT7 in the recruitment of monocyte-derived macrophages into lung tissue and COPD pathogenesis
Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation
Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial
Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study
Inhaled corticosteroids in COPD and the risk for coronary heart disease: a nationwide cohort study